Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010

Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010

Background: The Australian Pharmaceutical Benefits Scheme (PBS) first subsidized cholinesteraseinhibitors (CEIs) for Alzheimer’s disease in 2001, introducing a novel therapy fora previously untreatable common condition. This study aims to determine Australian rates ofCEI use and to assess equality o...

Full description

Bibliographic Details
Main Authors: Zilkens, Renate, Duke, Janine, Horner, Barbara, Semmens, James, Bruce, D.
Format: Journal Article
Published: Elsevier 2014
Subjects:
Remoteness
Alzheimer’s disease
Epidemiology
Socioeconomic disadvantage
Drug prescriptions
Age-specific rates
Cholinesterase inhibitors
Retrospective studies
Online Access:http://hdl.handle.net/20.500.11937/49254

Internet

http://hdl.handle.net/20.500.11937/49254

Similar Items